These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 25398823)

  • 1. Serum ferroxidase activity in patients with multiple sclerosis: a pilot study.
    Cervellati C; Romani A; Fainardi E; Trentini A; Squerzanti M; Baldi E; Caniatti ML; Granieri E; Bellini T; Castellazzi M
    In Vivo; 2014; 28(6):1197-200. PubMed ID: 25398823
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of total, ceruloplasmin-associated and type II ferroxidase activities in serum and cerebrospinal fluid of multiple sclerosis patients.
    Trentini A; Castellazzi M; Romani A; Squerzanti M; Baldi E; Caniatti ML; Pugliatti M; Granieri E; Fainardi E; Bellini T; Cervellati C
    J Neurol Sci; 2017 Jun; 377():133-136. PubMed ID: 28477683
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epstein-Barr virus-specific antibody response in cerebrospinal fluid and serum of patients with multiple sclerosis.
    Castellazzi M; Tamborino C; Cani A; Negri E; Baldi E; Seraceni S; Tola MR; Granieri E; Contini C; Fainardi E
    Mult Scler; 2010 Jul; 16(7):883-7. PubMed ID: 20483883
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Neurofilament protein light in multiple sclerosis].
    Zhang Y; Li X; Qiao J
    Zhonghua Yi Xue Za Zhi; 2007 Oct; 87(39):2745-9. PubMed ID: 18167263
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CSF levels of soluble HLA-G and Fas molecules are inversely associated to MRI evidence of disease activity in patients with relapsing-remitting multiple sclerosis.
    Fainardi E; Rizzo R; Melchiorri L; Stignani M; Castellazzi M; Tamborino C; Paolino E; Tola MR; Granieri E; Baricordi OR
    Mult Scler; 2008 May; 14(4):446-54. PubMed ID: 18208868
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intracellular oxidative activity and respiratory burst of leukocytes isolated from multiple sclerosis patients.
    Ferretti G; Bacchetti T; DiLudovico F; Viti B; Angeleri VA; Danni M; Provinciali L
    Neurochem Int; 2006 Jan; 48(2):87-92. PubMed ID: 16263194
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasmatic oxidative stress biomarkers in multiple sclerosis: relation with clinical and demographic characteristics.
    Pasquali L; Pecori C; Lucchesi C; LoGerfo A; Iudice A; Siciliano G; Bonuccelli U
    Clin Biochem; 2015 Jan; 48(1-2):19-23. PubMed ID: 25300461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and MRI disease activity in multiple sclerosis are associated with reciprocal fluctuations in serum and cerebrospinal fluid levels of soluble HLA class I molecules.
    Fainardi E; Granieri E; Tola MR; Melchiorri L; Vaghi L; Rizzo R; Castellazzi M; Ceruti S; Paolino E; Baricordi OR
    J Neuroimmunol; 2002 Dec; 133(1-2):151-9. PubMed ID: 12446018
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of haptoglobin phenotypes with ceruloplasmin ferroxidase activity in β-thalassemia major.
    Awadallah SM; Nimer NA; Atoum MF; Saleh SA
    Clin Chim Acta; 2011 May; 412(11-12):975-9. PubMed ID: 21315066
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CSF inflammation and axonal damage are increased and correlate in progressive multiple sclerosis.
    Romme Christensen J; Börnsen L; Khademi M; Olsson T; Jensen PE; Sørensen PS; Sellebjerg F
    Mult Scler; 2013 Jun; 19(7):877-84. PubMed ID: 23178691
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IL-15 is elevated in serum and cerebrospinal fluid of patients with multiple sclerosis.
    Rentzos M; Cambouri C; Rombos A; Nikolaou C; Anagnostouli M; Tsoutsou A; Dimitrakopoulos A; Triantafyllou N; Vassilopoulos D
    J Neurol Sci; 2006 Feb; 241(1-2):25-9. PubMed ID: 16316662
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in Serum Ceruloplasmin Levels Based on Immunomodulatory Treatments and Melatonin Supplementation in Multiple Sclerosis Patients.
    Adamczyk-Sowa M; Sowa P; Mucha S; Zostawa J; Mazur B; Owczarek M; Pierzchała K
    Med Sci Monit; 2016 Jul; 22():2484-91. PubMed ID: 27420299
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Soluble HLA-G molecules are released as HLA-G5 and not as soluble HLA-G1 isoforms in CSF of patients with relapsing-remitting multiple sclerosis.
    Fainardi E; Rizzo R; Melchiorri L; Stignani M; Castellazzi M; Caniatti ML; Baldi E; Tola MR; Granieri E; Baricordi OR
    J Neuroimmunol; 2007 Dec; 192(1-2):219-25. PubMed ID: 17997167
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of iron dysregulation in the pathogenesis of multiple sclerosis: an Egyptian study.
    Abo-Krysha N; Rashed L
    Mult Scler; 2008 Jun; 14(5):602-8. PubMed ID: 18408021
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum uric acid and multiple sclerosis.
    Sotgiu S; Pugliatti M; Sanna A; Sotgiu A; Fois ML; Arru G; Rosati G
    Neurol Sci; 2002 Oct; 23(4):183-8. PubMed ID: 12536287
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Parameters of antioxidant protection in multiple sclerosis].
    Krotenko NV; Alifirova VM; Ivanova SA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2009; 109(7 Suppl 2):53-6. PubMed ID: 19891349
    [TBL] [Abstract][Full Text] [Related]  

  • 17. sICAM-1 is not a marker for disease activity in the relapse-free interval of multiple sclerosis--a cross-sectional pilot study.
    Flachenecker P; Jung S; Rieckmann P; Toyka KV
    J Neurol; 2002 Aug; 249(8):1001-3. PubMed ID: 12195444
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of serum oxidant/antioxidant balance in multiple sclerosis.
    Acar A; Ugur Cevik M; Evliyaoglu O; Uzar E; Tamam Y; Arıkanoglu A; Yucel Y; Varol S; Onder H; Taşdemir N
    Acta Neurol Belg; 2012 Sep; 112(3):275-80. PubMed ID: 22450709
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased levels of IL-23 and osteopontin in serum and cerebrospinal fluid of multiple sclerosis patients.
    Wen SR; Liu GJ; Feng RN; Gong FC; Zhong H; Duan SR; Bi S
    J Neuroimmunol; 2012 Mar; 244(1-2):94-6. PubMed ID: 22329905
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cerebrospinal fluid levels of BAFF and APRIL in untreated multiple sclerosis.
    Piazza F; DiFrancesco JC; Fusco ML; Corti D; Pirovano L; Frigeni B; Mattavelli L; Andreoni S; Frigo M; Ferrarese C; Tredici G; Cavaletti G
    J Neuroimmunol; 2010 Mar; 220(1-2):104-7. PubMed ID: 20149932
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.